Healthcare - Biotechnology - NASDAQ - US
$ 18.61
0.649 %
$ 846 M
Market Cap
-20.91
P/E
Price Target
Average
54.04%
Revenue Forecast
Estimate
83.87%
EBIT
Estimate
--85.53%
Net Income
Estimate
58.91%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Capricor Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for CAPR of $28.7 , with forecasts ranging from a low of $14 to a high of $43 .
CAPR Lowest Price Target
Wall Street Target
14 USD
-24.77%
CAPR Average Price Target
Wall Street Target
28.7 USD
54.04%
CAPR Highest Price Target
Wall Street Target
43 USD
131.06%
REVENUE FORECAST
Revenue Forecast Chart CAPR
EBIT FORECAST
EBIT Forecast Chart CAPR
NET INCOME FORECAST
Net Income Chart CAPR